Cite
Videla-Richardson GA, Morris-Hanon O, Torres NI, et al. Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma. Int J Mol Sci. 2021;23(1)doi: 10.3390/ijms23010316.
Videla-Richardson, G. A., Morris-Hanon, O., Torres, N. I., Esquivel, M. I., Vera, M. B., Ripari, L. B., Croci, D. O., Sevlever, G. E., & Rabinovich, G. A. (2021). Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma. International journal of molecular sciences, 23(1), . https://doi.org/10.3390/ijms23010316
Videla-Richardson, Guillermo A, et al. "Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma." International journal of molecular sciences vol. 23,1 (2021). doi: https://doi.org/10.3390/ijms23010316
Videla-Richardson GA, Morris-Hanon O, Torres NI, Esquivel MI, Vera MB, Ripari LB, Croci DO, Sevlever GE, Rabinovich GA. Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma. Int J Mol Sci. 2021 Dec 28;23(1). doi: 10.3390/ijms23010316. PMID: 35008740; PMCID: PMC8745137.
Copy
Download .nbib